The prospect of artificial intelligence to personalize assisted reproductive technology.
Journal Information
Journal Title: NPJ Digit Med
Detailed journal information not available.
Publication Details
Subject Category: Medical Informatics
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing interests A.A. has received grants from the BRC; and has provided consulting services for Myovant Sciences Ltd. G.H.T. has stock in TFP; has received honoraria and travel support from Ferring Pharmaceuticals; and has provided consultancy services to ARC Medical Inc. S.M.N. received grants from NIHR, CSO, and BRC; provided consultancy services for Access Fertility, Modern Fertility, TFP, and Ferring Pharmaceuticals; received honoraria from Ferring Pharmaceuticals and Merck; received support for attending meetings and/or travel from Ferring Pharmaceuticals and Merck; participated in a data safety monitoring board or advisory board for NIHR; owns stock or stock options in TFP. W.S.D. received grants from NIHR, MRC, and Imperial Health Charity, and is a Consultant for Myovant Sciences Ltd. The remaining authors declare no competing interests."
"The Department of Metabolism, Digestion, and Reproduction is funded by grants from the MRC and NIHR. S.H. is supported by the UKRI CDT in AI for Healthcare http://ai4health.io (EP/S023283/1). A.A. is supported by an NIHR Clinician Scientist Award (CS-2018-18-ST2-002). M.V. and K.T.A. are supported by the EPSRC (EP/T017856/1). W.S.D. is supported by an NIHR Senior Investigator Award (NIHR202371). Competing interests: A.A. has received grants from the BRC; and has provided consulting services for Myovant Sciences Ltd. G.H.T. has stock in TFP; has received honoraria and travel support from Ferring Pharmaceuticals; and has provided consultancy services to ARC Medical Inc. S.M.N. received grants from NIHR, CSO, and BRC; provided consultancy services for Access Fertility, Modern Fertility, TFP, and Ferring Pharmaceuticals; received honoraria from Ferring Pharmaceuticals and Merck; received support for attending meetings and/or travel from Ferring Pharmaceuticals and Merck; participated in a data safety monitoring board or advisory board for NIHR; owns stock or stock options in TFP. W.S.D. received grants from NIHR, MRC, and Imperial Health Charity, and is a Consultant for Myovant Sciences Ltd. The remaining authors declare no competing interests."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025